The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms

DOI HANDLE HANDLE HANDLE PDF ほか1件をすべて表示 一部だけ表示 被引用文献21件 オープンアクセス

説明

<jats:title>Abstract</jats:title><jats:p>The upcoming 5th edition of the World Health Organization (WHO) Classification of Haematolymphoid Tumours is part of an effort to hierarchically catalogue human cancers arising in various organ systems within a single relational database. This paper summarizes the new WHO classification scheme for myeloid and histiocytic/dendritic neoplasms and provides an overview of the principles and rationale underpinning changes from the prior edition. The definition and diagnosis of disease types continues to be based on multiple clinicopathologic parameters, but with refinement of diagnostic criteria and emphasis on therapeutically and/or prognostically actionable biomarkers. While a genetic basis for defining diseases is sought where possible, the classification strives to keep practical worldwide applicability in perspective. The result is an enhanced, contemporary, evidence-based classification of myeloid and histiocytic/dendritic neoplasms, rooted in molecular biology and an organizational structure that permits future scalability as new discoveries continue to inexorably inform future editions.</jats:p>

収録刊行物

  • Leukemia

    Leukemia 36 (7), 1703-1719, 2022-06-22

    Springer Science and Business Media LLC

被引用文献 (21)*注記

もっと見る

キーワード

問題の指摘

ページトップへ